Study of BLZ-100 in Pediatric Subjects With CNS Tumors

Clinical trial NCT02462629 · COMPLETED

Trial details

NCT number: NCT02462629
Sponsor: Blaze Bioscience Inc.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Central Nervous System Tumors

Start date: 2015-06-01
Primary completion: 2018-07-01
Enrollment: 29

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.